APO Research
Talk to an analyst

APO RESEARCH · REPORT

Armodafinil

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Armodafinil Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchArmodafinil Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Armodafinil Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Armodafinil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Armodafinil Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Armodafinil Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Armodafinil market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Armodafinil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Armodafinil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Armodafinil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Armodafinil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Armodafinil include Apotex, Aurobindo, Lupin, Natco Pharma, Mylan, Sandoz and Teva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Armodafinil, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Armodafinil, also provides the revenue of main regions and countries. Of the upcoming market potential for Armodafinil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Armodafinil revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Armodafinil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Armodafinil revenue, projected growth trends, production technology, application and end-user industry.

Armodafinil Segment by Company

Apotex

Aurobindo

Lupin

Natco Pharma

Mylan

Sandoz

Teva

Armodafinil Segment by Type

50 mg Tablets

250 mg Tablets

200 mg Tablets

150 mg Tablets

Armodafinil Segment by Application

Obstructive Sleep Apnea (OSA) and Narcolepsy

Patients with Severe Hepatic Impairment

Shift Work Disorder (SWD)

Geriatric Patients

Armodafinil Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Armodafinil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Armodafinil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Armodafinil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Armodafinil in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Armodafinil company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Armodafinil revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Armodafinil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50 mg Tablets Major Player Table 3. 250 mg Tablets Major Player Table 4. 200 mg Tablets Major Player Table 5. 150 mg Tablets Major Player Table 6. Global Armodafinil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Obstructive Sleep Apnea (OSA) and Narcolepsy Major Player Table 8. Patients with Severe Hepatic Impairment Major Player Table 9. Shift Work Disorder (SWD) Major Player Table 10. Geriatric Patients Major Player Table 11. Armodafinil Industry Trends Table 12. Armodafinil Industry Drivers Table 13. Armodafinil Industry Opportunities and Challenges Table 14. Armodafinil Industry Restraints Table 15. Global Armodafinil Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Armodafinil Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Armodafinil Market Share by Region (2021-2026) Table 18. Global Armodafinil Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Armodafinil Market Share by Region (2027-2032) Table 20. Global Armodafinil Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Armodafinil Revenue Market Share by Players (2021-2026) Table 22. Global Armodafinil Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Armodafinil Key Players Headquarters & Area Served Table 24. Global Armodafinil Players, Product Type & Application Table 25. Global Armodafinil Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Armodafinil by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Armodafinil Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Armodafinil Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Armodafinil Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Armodafinil Revenue Market Share by Type (2021-2026) Table 32. Global Armodafinil Revenue Market Share by Type (2027-2032) Table 33. Global Armodafinil Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Armodafinil Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Armodafinil Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Armodafinil Revenue Market Share by Application (2021-2026) Table 37. Global Armodafinil Revenue Market Share by Application (2027-2032) Table 38. Apotex Company Information Table 39. Apotex Business Overview Table 40. Apotex Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Apotex Armodafinil Product Portfolio Table 42. Apotex Recent Development Table 43. Aurobindo Company Information Table 44. Aurobindo Business Overview Table 45. Aurobindo Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Aurobindo Armodafinil Product Portfolio Table 47. Aurobindo Recent Development Table 48. Lupin Company Information Table 49. Lupin Business Overview Table 50. Lupin Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Lupin Armodafinil Product Portfolio Table 52. Lupin Recent Development Table 53. Natco Pharma Company Information Table 54. Natco Pharma Business Overview Table 55. Natco Pharma Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Natco Pharma Armodafinil Product Portfolio Table 57. Natco Pharma Recent Development Table 58. Mylan Company Information Table 59. Mylan Business Overview Table 60. Mylan Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Mylan Armodafinil Product Portfolio Table 62. Mylan Recent Development Table 63. Sandoz Company Information Table 64. Sandoz Business Overview Table 65. Sandoz Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Sandoz Armodafinil Product Portfolio Table 67. Sandoz Recent Development Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Teva Armodafinil Product Portfolio Table 72. Teva Recent Development Table 73. North America Armodafinil Revenue by Type (2021-2026) & (US$ Million) Table 74. North America Armodafinil Revenue by Type (2027-2032) & (US$ Million) Table 75. North America Armodafinil Revenue by Application (2021-2026) & (US$ Million) Table 76. North America Armodafinil Revenue by Application (2027-2032) & (US$ Million) Table 77. North America Armodafinil Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. North America Armodafinil Revenue by Country (2021-2026) & (US$ Million) Table 79. North America Armodafinil Revenue by Country (US$ Million) & (2027-2032) Table 80. Europe Armodafinil Revenue by Type (2021-2026) & (US$ Million) Table 81. Europe Armodafinil Revenue by Type (2027-2032) & (US$ Million) Table 82. Europe Armodafinil Revenue by Application (2021-2026) & (US$ Million) Table 83. Europe Armodafinil Revenue by Application (2027-2032) & (US$ Million) Table 84. Europe Armodafinil Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. Europe Armodafinil Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Armodafinil Revenue by Country (US$ Million) & (2027-2032) Table 87. China Armodafinil Revenue by Type (2021-2026) & (US$ Million) Table 88. China Armodafinil Revenue by Type (2027-2032) & (US$ Million) Table 89. China Armodafinil Revenue by Application (2021-2026) & (US$ Million) Table 90. China Armodafinil Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Armodafinil Revenue by Type (2021-2026) & (US$ Million) Table 92. Asia Armodafinil Revenue by Type (2027-2032) & (US$ Million) Table 93. Asia Armodafinil Revenue by Application (2021-2026) & (US$ Million) Table 94. Asia Armodafinil Revenue by Application (2027-2032) & (US$ Million) Table 95. Asia Armodafinil Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Asia Armodafinil Revenue by Region (US$ Million) & (2021-2026) Table 97. Asia Armodafinil Revenue by Region (US$ Million) & (2027-2032) Table 98. SAMEA Armodafinil Revenue by Type (2021-2026) & (US$ Million) Table 99. SAMEA Armodafinil Revenue by Type (2027-2032) & (US$ Million) Table 100. SAMEA Armodafinil Revenue by Application (2021-2026) & (US$ Million) Table 101. SAMEA Armodafinil Revenue by Application (2027-2032) & (US$ Million) Table 102. SAMEA Armodafinil Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. SAMEA Armodafinil Revenue by Country (2021-2026) & (US$ Million) Table 104. SAMEA Armodafinil Revenue by Country (US$ Million) & (2027-2032) Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Armodafinil Image Figure 2. Global Armodafinil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Armodafinil Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50 mg Tablets Image Figure 5. 250 mg Tablets Image Figure 6. 200 mg Tablets Image Figure 7. 150 mg Tablets Image Figure 8. Global Armodafinil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Armodafinil Market Size Share 2021 VS 2025 VS 2032 Figure 10. Obstructive Sleep Apnea (OSA) and Narcolepsy Image Figure 11. Patients with Severe Hepatic Impairment Image Figure 12. Shift Work Disorder (SWD) Image Figure 13. Geriatric Patients Image Figure 14. Global Armodafinil Market Size (US$ Million) & (2021-2032) Figure 15. Global Armodafinil Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Armodafinil Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Armodafinil Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Armodafinil Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Armodafinil Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Armodafinil Revenue Market Share by Type (2021-2032) Figure 22. Global Armodafinil Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Armodafinil Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Armodafinil Revenue Market Share by Application (2021-2032) Figure 25. North America Armodafinil Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Armodafinil Revenue Share by Type (2021-2032) Figure 27. North America Armodafinil Revenue Share by Application (2021-2032) Figure 28. North America Armodafinil Revenue Share by Country (2021-2032) Figure 29. United States Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Armodafinil Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Armodafinil Revenue Share by Type (2021-2032) Figure 34. Europe Armodafinil Revenue Share by Application (2021-2032) Figure 35. Europe Armodafinil Revenue Share by Country (2021-2032) Figure 36. Germany Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Armodafinil Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Armodafinil Revenue Share by Type (2021-2032) Figure 46. China Armodafinil Revenue Share by Application (2021-2032) Figure 47. Asia Armodafinil Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Armodafinil Revenue Share by Type (2021-2032) Figure 49. Asia Armodafinil Revenue Share by Application (2021-2032) Figure 50. Asia Armodafinil Revenue Share by Region (2021-2032) Figure 51. Japan Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Armodafinil Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Armodafinil Revenue Share by Type (2021-2032) Figure 59. SAMEA Armodafinil Revenue Share by Application (2021-2032) Figure 60. SAMEA Armodafinil Revenue Share by Country (2021-2032) Figure 61. Brazil Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Armodafinil Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Tablets
  • 250 mg Tablets
  • 200 mg Tablets
  • 150 mg Tablets
Applications
  • Obstructive Sleep Apnea (OSA) and Narcolepsy
  • Patients with Severe Hepatic Impairment
  • Shift Work Disorder (SWD)
  • Geriatric Patients
Companies covered
  • Apotex
  • Aurobindo
  • Lupin
  • Natco Pharma
  • Mylan
  • Sandoz
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Armodafinil Market by Type
  3. 1.2.1 Global Armodafinil Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50 mg Tablets
  5. 1.2.3 250 mg Tablets
  6. 1.2.4 200 mg Tablets
  7. 1.2.5 150 mg Tablets
  8. 1.3 Armodafinil Market by Application
  9. 1.3.1 Global Armodafinil Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
  11. 1.3.3 Patients with Severe Hepatic Impairment
  12. 1.3.4 Shift Work Disorder (SWD)
  13. 1.3.5 Geriatric Patients
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Armodafinil Market Dynamics
  1. 2.1 Armodafinil Industry Trends
  2. 2.2 Armodafinil Industry Drivers
  3. 2.3 Armodafinil Industry Opportunities and Challenges
  4. 2.4 Armodafinil Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Armodafinil Market Perspective (2021-2032)
  2. 3.2 Global Armodafinil Growth Trends by Region
  3. 3.2.1 Global Armodafinil Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Armodafinil Market Size by Region (2021-2026)
  5. 3.2.3 Global Armodafinil Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Armodafinil Revenue by Players
  2. 4.1.1 Global Armodafinil Revenue by Players (2021-2026)
  3. 4.1.2 Global Armodafinil Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Armodafinil Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Armodafinil Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Armodafinil Key Players Headquarters & Area Served
  7. 4.4 Global Armodafinil Players, Product Type & Application
  8. 4.5 Global Armodafinil Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Armodafinil Market CR5 and HHI
  11. 4.6.3 2025 Armodafinil Tier 1, Tier 2, and Tier 3
5 Armodafinil Market Size by Type
  1. 5.1 Global Armodafinil Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Armodafinil Revenue by Type (2021-2032)
  3. 5.3 Global Armodafinil Revenue Market Share by Type (2021-2032)
6 Armodafinil Market Size by Application
  1. 6.1 Global Armodafinil Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Armodafinil Revenue by Application (2021-2032)
  3. 6.3 Global Armodafinil Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Apotex
  2. 7.1.1 Apotex Company Information
  3. 7.1.2 Apotex Business Overview
  4. 7.1.3 Apotex Armodafinil Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Apotex Armodafinil Product Portfolio
  6. 7.1.5 Apotex Recent Developments
  7. 7.2 Aurobindo
  8. 7.2.1 Aurobindo Company Information
  9. 7.2.2 Aurobindo Business Overview
  10. 7.2.3 Aurobindo Armodafinil Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Aurobindo Armodafinil Product Portfolio
  12. 7.2.5 Aurobindo Recent Developments
  13. 7.3 Lupin
  14. 7.3.1 Lupin Company Information
  15. 7.3.2 Lupin Business Overview
  16. 7.3.3 Lupin Armodafinil Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Lupin Armodafinil Product Portfolio
  18. 7.3.5 Lupin Recent Developments
  19. 7.4 Natco Pharma
  20. 7.4.1 Natco Pharma Company Information
  21. 7.4.2 Natco Pharma Business Overview
  22. 7.4.3 Natco Pharma Armodafinil Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Natco Pharma Armodafinil Product Portfolio
  24. 7.4.5 Natco Pharma Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Armodafinil Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Armodafinil Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Sandoz
  32. 7.6.1 Sandoz Company Information
  33. 7.6.2 Sandoz Business Overview
  34. 7.6.3 Sandoz Armodafinil Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz Armodafinil Product Portfolio
  36. 7.6.5 Sandoz Recent Developments
  37. 7.7 Teva
  38. 7.7.1 Teva Company Information
  39. 7.7.2 Teva Business Overview
  40. 7.7.3 Teva Armodafinil Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Teva Armodafinil Product Portfolio
  42. 7.7.5 Teva Recent Developments
8 North America
  1. 8.1 North America Armodafinil Revenue (2021-2032)
  2. 8.2 North America Armodafinil Revenue by Type (2021-2032)
  3. 8.2.1 North America Armodafinil Revenue by Type (2021-2026)
  4. 8.2.2 North America Armodafinil Revenue by Type (2027-2032)
  5. 8.3 North America Armodafinil Revenue Share by Type (2021-2032)
  6. 8.4 North America Armodafinil Revenue by Application (2021-2032)
  7. 8.4.1 North America Armodafinil Revenue by Application (2021-2026)
  8. 8.4.2 North America Armodafinil Revenue by Application (2027-2032)
  9. 8.5 North America Armodafinil Revenue Share by Application (2021-2032)
  10. 8.6 North America Armodafinil Revenue by Country
  11. 8.6.1 North America Armodafinil Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Armodafinil Revenue by Country (2021-2026)
  13. 8.6.3 North America Armodafinil Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Armodafinil Revenue (2021-2032)
  2. 9.2 Europe Armodafinil Revenue by Type (2021-2032)
  3. 9.2.1 Europe Armodafinil Revenue by Type (2021-2026)
  4. 9.2.2 Europe Armodafinil Revenue by Type (2027-2032)
  5. 9.3 Europe Armodafinil Revenue Share by Type (2021-2032)
  6. 9.4 Europe Armodafinil Revenue by Application (2021-2032)
  7. 9.4.1 Europe Armodafinil Revenue by Application (2021-2026)
  8. 9.4.2 Europe Armodafinil Revenue by Application (2027-2032)
  9. 9.5 Europe Armodafinil Revenue Share by Application (2021-2032)
  10. 9.6 Europe Armodafinil Revenue by Country
  11. 9.6.1 Europe Armodafinil Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Armodafinil Revenue by Country (2021-2026)
  13. 9.6.3 Europe Armodafinil Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Armodafinil Revenue (2021-2032)
  2. 10.2 China Armodafinil Revenue by Type (2021-2032)
  3. 10.2.1 China Armodafinil Revenue by Type (2021-2026)
  4. 10.2.2 China Armodafinil Revenue by Type (2027-2032)
  5. 10.3 China Armodafinil Revenue Share by Type (2021-2032)
  6. 10.4 China Armodafinil Revenue by Application (2021-2032)
  7. 10.4.1 China Armodafinil Revenue by Application (2021-2026)
  8. 10.4.2 China Armodafinil Revenue by Application (2027-2032)
  9. 10.5 China Armodafinil Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Armodafinil Revenue (2021-2032)
  2. 11.2 Asia Armodafinil Revenue by Type (2021-2032)
  3. 11.2.1 Asia Armodafinil Revenue by Type (2021-2026)
  4. 11.2.2 Asia Armodafinil Revenue by Type (2027-2032)
  5. 11.3 Asia Armodafinil Revenue Share by Type (2021-2032)
  6. 11.4 Asia Armodafinil Revenue by Application (2021-2032)
  7. 11.4.1 Asia Armodafinil Revenue by Application (2021-2026)
  8. 11.4.2 Asia Armodafinil Revenue by Application (2027-2032)
  9. 11.5 Asia Armodafinil Revenue Share by Application (2021-2032)
  10. 11.6 Asia Armodafinil Revenue by Country
  11. 11.6.1 Asia Armodafinil Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Armodafinil Revenue by Country (2021-2026)
  13. 11.6.3 Asia Armodafinil Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Armodafinil Revenue (2021-2032)
  2. 12.2 SAMEA Armodafinil Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Armodafinil Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Armodafinil Revenue by Type (2027-2032)
  5. 12.3 SAMEA Armodafinil Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Armodafinil Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Armodafinil Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Armodafinil Revenue by Application (2027-2032)
  9. 12.5 SAMEA Armodafinil Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Armodafinil Revenue by Country
  11. 12.6.1 SAMEA Armodafinil Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Armodafinil Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Armodafinil Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst